FDA Takes “Fresh Look” At ORA Reorg, Eyes Outsourcing Some Agency Posts
This article was originally published in The Gray Sheet
Executive SummaryFDA's Office of Regulatory Affairs still plans to reorganize, despite its recent decision to cancel the planned closure of seven field labs
You may also be interested in...
The reorganized ORA has eight new offices to better handle new legislative authorities and globalization of its regulated products; FDA expects to increase partnerships with other government officials and foreign entities.